 | • レポートコード：MRC2-11QY00262 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性閉塞性肺疾患治療のグローバル市場について調査・分析したレポートです。種類別（臭化ウメクリジニウム・トリフェナチン酸ビランテロール粉末、肺炎球菌ワクチン）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性閉塞性肺疾患治療の競争状況、市場シェア ・世界の慢性閉塞性肺疾患治療市場：種類別市場規模 2015年-2020年（臭化ウメクリジニウム・トリフェナチン酸ビランテロール粉末、肺炎球菌ワクチン） ・世界の慢性閉塞性肺疾患治療市場：種類別市場規模予測 2021年-2026年（臭化ウメクリジニウム・トリフェナチン酸ビランテロール粉末、肺炎球菌ワクチン） ・世界の慢性閉塞性肺疾患治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の慢性閉塞性肺疾患治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の慢性閉塞性肺疾患治療市場分析：米国、カナダ ・ヨーロッパの慢性閉塞性肺疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性閉塞性肺疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性閉塞性肺疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性閉塞性肺疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Pfizer、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Treatment Market
The global Chronic Obstructive Pulmonary Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chronic Obstructive Pulmonary Disease Treatment Scope and Market Size
Chronic Obstructive Pulmonary Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Obstructive Pulmonary Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chronic Obstructive Pulmonary Disease Treatment market is segmented into
Umeclidinium Bromide and Vilanterol Trifenatate Powder
Pneumonia Vaccine
Segment by Application, the Chronic Obstructive Pulmonary Disease Treatment market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Chronic Obstructive Pulmonary Disease Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Obstructive Pulmonary Disease Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Obstructive Pulmonary Disease Treatment Market Share Analysis
Chronic Obstructive Pulmonary Disease Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Obstructive Pulmonary Disease Treatment business, the date to enter into the Chronic Obstructive Pulmonary Disease Treatment market, Chronic Obstructive Pulmonary Disease Treatment product introduction, recent developments, etc.
The major vendors covered:
GSK
Pfizer
Merck
…
1 Study Coverage
1.1 Chronic Obstructive Pulmonary Disease Treatment Product Introduction
1.2 Market Segments
1.3 Key Chronic Obstructive Pulmonary Disease Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Obstructive Pulmonary Disease Treatment Market Size Growth Rate by Type
1.4.2 Umeclidinium Bromide and Vilanterol Trifenatate Powder
1.4.3 Pneumonia Vaccine
1.5 Market by Application
1.5.1 Global Chronic Obstructive Pulmonary Disease Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Chronic Obstructive Pulmonary Disease Treatment Market Size, Estimates and Forecasts
2.1.1 Global Chronic Obstructive Pulmonary Disease Treatment Revenue 2015-2026
2.1.2 Global Chronic Obstructive Pulmonary Disease Treatment Sales 2015-2026
2.2 Global Chronic Obstructive Pulmonary Disease Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Obstructive Pulmonary Disease Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chronic Obstructive Pulmonary Disease Treatment Competitor Landscape by Players
3.1 Chronic Obstructive Pulmonary Disease Treatment Sales by Manufacturers
3.1.1 Chronic Obstructive Pulmonary Disease Treatment Sales by Manufacturers (2015-2020)
3.1.2 Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Obstructive Pulmonary Disease Treatment Revenue by Manufacturers
3.2.1 Chronic Obstructive Pulmonary Disease Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Obstructive Pulmonary Disease Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Obstructive Pulmonary Disease Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Treatment Revenue in 2019
3.2.5 Global Chronic Obstructive Pulmonary Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Obstructive Pulmonary Disease Treatment Price by Manufacturers
3.4 Chronic Obstructive Pulmonary Disease Treatment Manufacturing Base Distribution, Product Types
3.4.1 Chronic Obstructive Pulmonary Disease Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Obstructive Pulmonary Disease Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Obstructive Pulmonary Disease Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Obstructive Pulmonary Disease Treatment Market Size by Type (2015-2020)
4.1.1 Global Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020)
4.1.2 Global Chronic Obstructive Pulmonary Disease Treatment Revenue by Type (2015-2020)
4.1.3 Chronic Obstructive Pulmonary Disease Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Obstructive Pulmonary Disease Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Obstructive Pulmonary Disease Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Chronic Obstructive Pulmonary Disease Treatment Market Size by Application (2015-2020)
5.1.1 Global Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020)
5.1.2 Global Chronic Obstructive Pulmonary Disease Treatment Revenue by Application (2015-2020)
5.1.3 Chronic Obstructive Pulmonary Disease Treatment Price by Application (2015-2020)
5.2 Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Obstructive Pulmonary Disease Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Chronic Obstructive Pulmonary Disease Treatment by Country
6.1.1 North America Chronic Obstructive Pulmonary Disease Treatment Sales by Country
6.1.2 North America Chronic Obstructive Pulmonary Disease Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Type
6.3 North America Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disease Treatment by Country
7.1.1 Europe Chronic Obstructive Pulmonary Disease Treatment Sales by Country
7.1.2 Europe Chronic Obstructive Pulmonary Disease Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Type
7.3 Europe Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Chronic Obstructive Pulmonary Disease Treatment by Region
8.1.1 Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales by Region
8.1.2 Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Type
8.3 Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disease Treatment by Country
9.1.1 Latin America Chronic Obstructive Pulmonary Disease Treatment Sales by Country
9.1.2 Latin America Chronic Obstructive Pulmonary Disease Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Type
9.3 Central & South America Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment by Country
10.1.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales by Country
10.1.2 Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Chronic Obstructive Pulmonary Disease Treatment Products Offered
11.1.5 GSK Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Chronic Obstructive Pulmonary Disease Treatment Products Offered
11.2.5 Pfizer Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Chronic Obstructive Pulmonary Disease Treatment Products Offered
11.3.5 Merck Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Chronic Obstructive Pulmonary Disease Treatment Products Offered
11.1.5 GSK Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chronic Obstructive Pulmonary Disease Treatment Market Estimates and Projections by Region
12.1.1 Global Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast (2021-2026)
12.2.2 North America: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Obstructive Pulmonary Disease Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Obstructive Pulmonary Disease Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Obstructive Pulmonary Disease Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Chronic Obstructive Pulmonary Disease Treatment Market Segments
Table 2. Ranking of Global Top Chronic Obstructive Pulmonary Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Obstructive Pulmonary Disease Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Umeclidinium Bromide and Vilanterol Trifenatate Powder
Table 5. Major Manufacturers of Pneumonia Vaccine
Table 6. Global Chronic Obstructive Pulmonary Disease Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Chronic Obstructive Pulmonary Disease Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Chronic Obstructive Pulmonary Disease Treatment Sales by Regions 2015-2020 (K Units)
Table 9. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Regions (2015-2020)
Table 10. Global Chronic Obstructive Pulmonary Disease Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Chronic Obstructive Pulmonary Disease Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Chronic Obstructive Pulmonary Disease Treatment Sales Share by Manufacturers (2015-2020)
Table 13. Global Chronic Obstructive Pulmonary Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Chronic Obstructive Pulmonary Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease Treatment as of 2019)
Table 15. Chronic Obstructive Pulmonary Disease Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Chronic Obstructive Pulmonary Disease Treatment Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Chronic Obstructive Pulmonary Disease Treatment Price (2015-2020) (US$/Unit)
Table 18. Chronic Obstructive Pulmonary Disease Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Chronic Obstructive Pulmonary Disease Treatment Product Type
Table 20. Date of International Manufacturers Enter into Chronic Obstructive Pulmonary Disease Treatment Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020) (K Units)
Table 23. Global Chronic Obstructive Pulmonary Disease Treatment Sales Share by Type (2015-2020)
Table 24. Global Chronic Obstructive Pulmonary Disease Treatment Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Share by Type (2015-2020)
Table 26. Chronic Obstructive Pulmonary Disease Treatment Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 27. Global Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020) (K Units)
Table 28. Global Chronic Obstructive Pulmonary Disease Treatment Sales Share by Application (2015-2020)
Table 29. North America Chronic Obstructive Pulmonary Disease Treatment Sales by Country (2015-2020) (K Units)
Table 30. North America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country (2015-2020)
Table 31. North America Chronic Obstructive Pulmonary Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country (2015-2020)
Table 33. North America Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020) (K Units)
Table 34. North America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type (2015-2020)
Table 35. North America Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020) (K Units)
Table 36. North America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application (2015-2020)
Table 37. Europe Chronic Obstructive Pulmonary Disease Treatment Sales by Country (2015-2020) (K Units)
Table 38. Europe Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country (2015-2020)
Table 39. Europe Chronic Obstructive Pulmonary Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country (2015-2020)
Table 41. Europe Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020) (K Units)
Table 42. Europe Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type (2015-2020)
Table 43. Europe Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020) (K Units)
Table 44. Europe Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application (2015-2020)
Table 53. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales by Country (2015-2020) (K Units)
Table 54. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Chronic Obstructive Pulmonary Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country (2015-2020)
Table 57. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020) (K Units)
Table 58. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type (2015-2020)
Table 59. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020) (K Units)
Table 60. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application (2015-2020)
Table 69. GSK Corporation Information
Table 70. GSK Description and Major Businesses
Table 71. GSK Chronic Obstructive Pulmonary Disease Treatment Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 72. GSK Product
Table 73. GSK Recent Development
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Chronic Obstructive Pulmonary Disease Treatment Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Chronic Obstructive Pulmonary Disease Treatment Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Global Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 85. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 86. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 87. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 88. North America: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 89. North America: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Europe: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 91. Europe: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 92. Asia Pacific: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 93. Asia Pacific: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Latin America: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 95. Latin America: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Middle East and Africa: Chronic Obstructive Pulmonary Disease Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 97. Middle East and Africa: Chronic Obstructive Pulmonary Disease Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Market Risks
Table 101. Main Points Interviewed from Key Chronic Obstructive Pulmonary Disease Treatment Players
Table 102. Chronic Obstructive Pulmonary Disease Treatment Customers List
Table 103. Chronic Obstructive Pulmonary Disease Treatment Distributors List
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Obstructive Pulmonary Disease Treatment Product Picture
Figure 2. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Umeclidinium Bromide and Vilanterol Trifenatate Powder Product Picture
Figure 4. Pneumonia Vaccine Product Picture
Figure 5. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Chronic Obstructive Pulmonary Disease Treatment Report Years Considered
Figure 9. Global Chronic Obstructive Pulmonary Disease Treatment Market Size 2015-2026 (US$ Million)
Figure 10. Global Chronic Obstructive Pulmonary Disease Treatment Sales 2015-2026 (K Units)
Figure 11. Global Chronic Obstructive Pulmonary Disease Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Region (2015-2020)
Figure 13. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Region in 2019
Figure 14. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Region (2015-2020)
Figure 15. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Region in 2019
Figure 16. Global Chronic Obstructive Pulmonary Disease Treatment Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Treatment Revenue in 2019
Figure 18. Chronic Obstructive Pulmonary Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type (2015-2020)
Figure 20. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Type in 2019
Figure 21. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Type (2015-2020)
Figure 22. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Type in 2019
Figure 23. Global Chronic Obstructive Pulmonary Disease Treatment Market Share by Price Range (2015-2020)
Figure 24. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application (2015-2020)
Figure 25. Global Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Application in 2019
Figure 26. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Application (2015-2020)
Figure 27. Global Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Application in 2019
Figure 28. North America Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country in 2019
Figure 31. North America Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country in 2019
Figure 32. U.S. Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Chronic Obstructive Pulmonary Disease Treatment Market Share by Type in 2019
Figure 37. North America Chronic Obstructive Pulmonary Disease Treatment Market Share by Application in 2019
Figure 38. Europe Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country in 2019
Figure 41. Europe Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country in 2019
Figure 42. Germany Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Chronic Obstructive Pulmonary Disease Treatment Market Share by Type in 2019
Figure 53. Europe Chronic Obstructive Pulmonary Disease Treatment Market Share by Application in 2019
Figure 54. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Region in 2019
Figure 57. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Region in 2019
Figure 58. China Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Market Share by Type in 2019
Figure 81. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Market Share by Application in 2019
Figure 82. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country in 2019
Figure 85. Latin America Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country in 2019
Figure 86. Mexico Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Chronic Obstructive Pulmonary Disease Treatment Market Share by Type in 2019
Figure 93. Latin America Chronic Obstructive Pulmonary Disease Treatment Market Share by Application in 2019
Figure 94. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Revenue Market Share by Country in 2019
Figure 98. Turkey Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 103. UAE Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Market Share by Type in 2019
Figure 105. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Market Share by Application in 2019
Figure 106. North America Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Chronic Obstructive Pulmonary Disease Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
慢性閉塞性肺疾患（COPD）の世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…- 慢性血栓塞栓性肺高血圧症（CTEPH）の世界市場（～2026年） Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Heal…
- 慢性腎臓病（CKD）の世界市場（～2026年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Kidney Disease (CKD) Scope and Market Size Chroni…
- 慢性肺疾患治療の世界市場（～2026年） Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…
- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…